DMT-assisted therapy: changing the way we think about depressive disorders

A ‘spirit molecule’ from the Amazon could be a game changer in the treatment of major depressive disorders. Dr Carol Routledge, of Small Pharma, talks to Karen Southern about her pioneering work with DMT. Psychedelic...

2022: The year for UK Life Sciences?

Charles Walford, Senior Development Director and Head of Life Sciences, Stanhope PLC, considers the opportunities and challenges facing the UK’s life sciences ecosystem. The past two years have propelled life sciences into the mainstream. The...

Personalised medicine: driving a need for greater diversity

Kate Shaw, CEO of Innovative Trials, investigates one of the biggest challenges facing clinical research today. Personalised medicines, particularly gene and cell therapies, offer new opportunities for treating serious conditions such as muscular dystrophy, cystic fibrosis...

Acesis breaks new ground with novel therapy solution to low testosterone

For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could...

Is your Invention Plausible?

Alex Bone, Patent Attorney, Partner,  AA Thornton The market exclusivity provided by a patent can be crucial for allowing a company to obtain a return on their R&D investment. A patent is essentially a deal in which,...

AI used to improve cardiovascular risk prediction

AI startup Owkin and Amgen have announced the results of a three-year project using artificial intelligence to more accurately predict cardiovascular risk. This study demonstrates the ability of AI to improve the way that...

Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on...

Bacteria can develop strong immunity for protection against viruses

A new study hopes to exploit newly characterised defence systems in bacteria to compare changes to the human genome. University bioscientists have been working on the research to demonstrate the complex workings of bacterial innate...

Light therapy helmet could help dementia patients

A new infrared light therapy has the potential to help people with dementia. A pilot study recently investigated how transcranial photobiomodulation therapy (PBM-T) –transferred through a specially adapted helmet -- could boost memory, motor function...

Putting the diverse into neurodiversity

The global Institute Of Neurodiversity ION has launched its UK chapter. The Institute aims to give a global voice to all neurodiverse groups, and ensure neurodivergent individuals are understood, represented, and valued equally in society. Currently, 1 in...

Sizzling breakthrough for 3D meat

A 4oz steak has been ‘lab-grown’ using a digital design file. Israeli firm MeaTech 3D Ltd. cultivated the bio-printed steak using real fat and muscle cells. The cells were produced using an advanced process that...

‘Super jelly’ can survive being run over by a car

Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80 per cent water. The soft-yet-strong material, developed...

New microscope uses photonics for insights into ‘superbugs’

Scientists are building a new super-resolution microscope that uses laser light to study the inner workings and behaviours of superbugs to gain new insights into how they cause disease. The microscope will allow scientists to...

Shaping the science of oncology

Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs. From the day that Dr McLaughlin –...

Biotech pioneer tackles the biology of ageing

Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen...

Euro biotech: breaking down the barriers to a golden age

Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality. Europe’s tech sector is going from strength to strength....